Business StandardCenter·
Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD
Specialty chemicals manufacturer Epigral is targeting revenue of Rs 5,000 crore by 2030-31, driven by upcoming production scale-ups in CPVC Resin and Epichlorohydrin (ECH), a senior company executive said. The company expects to reach Rs 2,900 crore in revenue this fiscal year following revenue of Rs 2,5002,530 crore in 2026. "In FY26, we ended with around Rs 2,500-2,530 crore of revenue, and at the current pace of growth, we expect around Rs 2,900 crore this financial year. "The capacity incre…
Read at Business Standard →
